Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/30/2010US20100331305 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100331303 Prolyl hydroxylase inhibitors and methods of use
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331301 Azetidine compound and pharmaceutical use thereof
12/30/2010US20100331300 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331299 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100331297 Modulation of protein trafficking
12/30/2010US20100331296 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331294 4-substituted-2-amino-pyrimidine derivatives
12/30/2010US20100331293 Heterocyclic compounds and their uses
12/30/2010US20100331292 Substituted 16,17-annellated steriod compounds for use in womens healthcare
12/30/2010US20100331291 Process for the preparation of drospirenone
12/30/2010US20100331290 Taxane delivery system
12/30/2010US20100331289 Combination of Azelastine and Steroids
12/30/2010US20100331288 Crystalline hydrate of betamimetika and use as medicament thereof
12/30/2010US20100331287 6-(Aminoalkyl)Indazoles
12/30/2010US20100331286 Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
12/30/2010US20100331285 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same
12/30/2010US20100331284 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100331282 Pyridine derivative containing ((phosphonooxy)methyl)pyridinium ring, and antifungal agent containing these derivative
12/30/2010US20100331281 Phospholipid compositions and uses thereof
12/30/2010US20100331280 Modulation of the Phospholipase A2 Pathway as a Therapeutic
12/30/2010US20100331279 Inhibition of Antigen Presentation with Poorly Catabolized Polymers
12/30/2010US20100331278 Uses of cationic hydroxyethylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
12/30/2010US20100331277 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
12/30/2010US20100331276 Topical compositions and the use thereof
12/30/2010US20100331275 Supporting activities of daily living
12/30/2010US20100331274 Antiaging Chirally-Correct Mitoprotectant Amino Acid and Peptide Complexes
12/30/2010US20100331273 Self-assembling complex for targeting chemical agents to cells
12/30/2010US20100331272 Agent for Preventing or Ameliorating Skin Aging
12/30/2010US20100331271 Use of Acacetin and Related Compounds as Potassium Channel Inhibitors
12/30/2010US20100331270 Adrenomedullin production enhancer
12/30/2010US20100331269 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
12/30/2010US20100331268 Nitrated Lipids and Methods of Making and Using Thereof
12/30/2010US20100331267 Use of cyclohexanehexol derivatives in the treatment of alpha-synucleinopathies
12/30/2010US20100331258 memory in subjects with mini-mental state examination of 24-26
12/30/2010US20100331248 Compositions and methods for treating diabetes using lisofylline and islet neogenesis associated peptide
12/30/2010US20100331247 Peptide therapy for hyperglycemia
12/30/2010US20100331237 Gag binding proteins
12/30/2010US20100331235 Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/30/2010US20100331232 Starch-based hydrogel for biomedical applications
12/30/2010US20100330673 Methods of making enhanced, autologous fat grafts
12/30/2010US20100330586 Method for identifying compounds for treatment of pain
12/30/2010US20100330215 Methods of Administering Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitors
12/30/2010US20100330213 Estrogenic Extracts of Morus Alba and Uses Thereof
12/30/2010US20100330212 Skin sensitizer delivery system
12/30/2010US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements
12/30/2010US20100330201 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
12/30/2010US20100330199 Isothiazole-pyridine derivates as modulators of hif (hypoxia inducible factor) activity
12/30/2010US20100330198 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/30/2010US20100330193 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
12/30/2010US20100330189 Sustained release beads and suspensions including the same for sustained delivery of active ingredients
12/30/2010US20100330187 Capsicum food additive and uses thereof
12/30/2010US20100330186 Medicaments for inhalation comprising an anticholinergic and a betamimetic
12/30/2010US20100330184 Injection vehicle for polymer-based formulations
12/30/2010US20100330179 Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
12/30/2010US20100330178 Extended release compositions comprising as active compound venlafaxine hydrochloride
12/30/2010US20100330177 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/30/2010US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
12/30/2010US20100330175 Cross-linked polyallylamine tablet core
12/30/2010US20100330174 Betaine compositions
12/30/2010US20100330173 Compounds and methods for treating influenza
12/30/2010US20100330172 Controlled-release pharmaceutical formulation
12/30/2010US20100330171 Dietary Supplement for Eye Health
12/30/2010US20100330168 Pharmaceutical composition based on micronized progesterone and uses thereof
12/30/2010US20100330167 Nanoparticles for protein drug delivery
12/30/2010US20100330166 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
12/30/2010US20100330165 Use of chemotherapeutic agents
12/30/2010US20100330164 Method of increasing tear production with purinergic receptor agonists
12/30/2010US20100330163 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies
12/30/2010US20100330162 Spray freeze dry of compositions for pulmonary adminstration
12/30/2010US20100330160 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6
12/30/2010US20100330159 System for transporting active substances in a biological system
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330156 Phenazine derivatives and uses thereof
12/30/2010US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
12/30/2010US20100330154 amphoteric liposomes comprising neutral lipids
12/30/2010US20100330152 Methods and compositons for antisense vegf oligonucleotides
12/30/2010US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
12/30/2010US20100330149 Solid Drug Tablets for Implantable Drug Delivery Devices
12/30/2010US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1
12/30/2010US20100330146 Contact lenses for extended release of bioactive agents containing diffusion attenuators
12/30/2010US20100330145 Biobeneficial coating compositions and methods of making and using thereof
12/30/2010US20100330143 Modified macromolecules and methods of making and using thereof
12/30/2010US20100330138 Biostable, multipurpose, microbicidal intravaginal devices
12/30/2010US20100330131 Minocycline oral dosage forms for the treatment of acne
12/30/2010US20100330130 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
12/30/2010US20100330129 Gastroresistant Pharmaceutical Formulations Containing Rifaximin
12/30/2010US20100330125 Novel polysaccharide immunogens from clostridium difficile
12/30/2010US20100330114 Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330098 Methods to regulate glucose metabolism
12/30/2010US20100330097 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
12/30/2010US20100330086 Cationic steroid antimicrobial compositions and methods of use
12/30/2010US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
1 ... 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 ... 7860